Related Experiment Video
Updated: Aug 12, 2026

An In Vitro Approach to Study Mitochondrial Dysfunction: A Cybrid Model
Published on: March 9, 2022
Disease-related versus polymorphic mutations in human mitochondrial tRNAs. Where is the difference?
1UPR 9002 du CNRS, Département Mécanismes et Macromolécules de la Synthèse Protéique et Cristallogenèse, Institut de Biologie Moléculaire et Cellulaire, 15 rue René Descartes, F-67084 Strasbourg Cedex, France. C.Florentz@ibmc.u-strasbg.fr
Point mutations in human mitochondrial tRNA genes cause severe disorders. Basic structural analysis cannot predict mutation pathogenicity, necessitating individual molecular investigation for accurate diagnosis.
Area of Science:
- Mitochondrial genetics
- Molecular biology
- Human genetics
Background:
- Point mutations in human mitochondrial (mt) tRNA genes are linked to severe neuromuscular and other disorders.
- The complex genotype/phenotype correlations and diverse molecular impacts of these mutations require unifying analytical features.
- The rapid discovery of new mutations necessitates efficient methods for assessing pathogenicity.
Purpose of the Study:
- To compare basic structural features of pathogenic and neutral mt tRNA mutations.
- To determine if standard parameters can predict the pathogenicity of mt tRNA mutations.
- To highlight the need for case-by-case molecular investigation.
Main Methods:
- Comparison of primary and secondary structure features.
- Analysis of 68 pathogenic mt tRNA mutations.
- Analysis of 64 polymorphic (neutral) mt tRNA mutations.
Main Results:
- Standard parameters of primary and secondary structure are insufficient for predicting pathogenicity.
- No unifying structural features were identified that distinguish pathogenic from neutral mutations.
- The study underscores the limitations of basic structural analysis in predicting disease association.
Conclusions:
- Individual molecular investigation is currently the only reliable method for assessing pathogenic mt tRNA mutations.
- Predicting pathogenicity based solely on basic structural features is not feasible.
- Further research into novel analytical approaches is warranted.
Related Concept Videos
Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Animal Mitochondrial Genetics
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Principles of Pharmacogenetics: Types of Genetic Variants

